Your browser doesn't support javascript.
loading
Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors.
Martin, Alexandra L; Anadon, Carmen M; Biswas, Subir; Mine, Jessica A; Handley, Katelyn F; Payne, Kyle K; Mandal, Gunjan; Chaurio, Ricardo A; Powers, John J; Sprenger, Kimberly B; Rigolizzo, Kristen E; Innamarato, Patrick; Harro, Carly M; Mehta, Sumit; Perez, Bradford A; Wenham, Robert M; Conejo-Garcia, Jose R.
Afiliação
  • Martin AL; Department of Clinical Science, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Anadon CM; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Biswas S; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Mine JA; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Handley KF; Gynecologic Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Payne KK; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Morsani College of Medicine, University of South Florida, Tampa, Florida.
  • Mandal G; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Chaurio RA; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Powers JJ; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Sprenger KB; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Rigolizzo KE; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Innamarato P; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Harro CM; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Mehta S; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Perez BA; Gynecologic Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Wenham RM; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Morsani College of Medicine, University of South Florida, Tampa, Florida.
  • Conejo-Garcia JR; Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Mol Cancer Ther ; 21(7): 1184-1194, 2022 07 05.
Article em En | MEDLINE | ID: mdl-35499393
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Receptores Odorantes / Neoplasias Epiteliais e Glandulares / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Receptores Odorantes / Neoplasias Epiteliais e Glandulares / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos